Showing 2 of 2 recruiting trials for “familial-osteodysplasia-anderson-type”
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
RecruitingNCT01247597 ↗
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
👨⚕️ Douglas R Stewart, M.D., National Cancer Institute (NCI)📍 2 sites📅 Started Feb 2011View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →